© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Urea pharmaceutical grade is a purified chemical material known for its high quality standards, ensuring suitability for pharmaceutical applications. In the context of both medicine and industry, it stands apart because of its purity, minimal impurities, and compliance with rigorous health and safety regulations. The compound appears in several forms, including solid, flakes, crystalline, powder, pearls, and sometimes even as a solution, each adapted for various processes and formulations.
Urea carries the molecular formula CO(NH2)2, translating to a straightforward yet versatile structure. Two amine groups attach to a carbonyl group, creating a compact molecule with robust stability. The molecular weight measures 60.06 g/mol, which guides calculations in pharmaceutical manufacturing and labeling. This compound dissolves well in water, owing to its polar nature, and produces a colorless solution that maintains neutrality in pH. In solid form, it forms white crystals, flakes, or powder, each differing slightly in density and flow properties. The density typically stands at around 1.32 g/cm³, which helps guide storage and handling decisions in both laboratory and industrial settings.
Cooling urea from a hot solution results in the formation of clear crystals or flakes. These solid materials handle well, showing high stability under normal atmospheric conditions. Urea melts at roughly 132.7°C, which means heat-based applications demand attention to avoid premature melting or degradation. As a raw material in pharmaceutical use, its consistent particle size and purity support accurate dosing in final products. The compound’s physical flexibility—solid, powder, pearls, and more—creates pathways for multiple product types, whether tablets, creams, or injectable solutions. Since moisture can affect urea’s properties, storage in tightly-sealed containers becomes essential to maintain quality.
Sticking to pharmaceutical grade means tight control over potential impurities, with safety assessments conducted as part of compliance with established pharmacopeial standards. Urea itself poses low acute toxicity when handled properly, but dust or powder forms may sometimes irritate the eyes, skin, or respiratory tract if handled without care. Chronic exposure risks stay minimal when standard protective measures are respected, such as wearing gloves and protective eyewear. The substance holds a UN number and HS Code—HS Code 283110 for customs and trade—ensuring traceability and proper global transport. Safety Data Sheets outline guidelines for accidental release, fire-fighting, and disposal, helping ensure safe use at every step, from factory to pharmacy.
Urea’s most recognizable presence in pharmaceuticals comes from its role as a keratolytic agent, meaning it helps break down tough skin and increases the moisture content of the skin layers. Creams and ointments containing this material provide relief for dry skin conditions, eczema, and other dermatological issues. In topical preparations, characteristics like fine powder or pearl form encourage easy mixing and smooth application. Some specialty injectables rely on urea’s solubility for effective drug delivery, demonstrating flexibility as a raw material. Large-scale production benefits from consistent specifications—purity typically above 99%—as this prevents batch discrepancies and ensures the finished pharmaceutical product stays reliable and safe for patients.
Typical specifications focus on maintaining very low biuret content, limited heavy metals, and minimal organic or inorganic contamination. Inspection batches draw from standards set by worldwide regulatory bodies, which helps avoid complications in registration and sale across borders. The packing options stretch from small containers for laboratory trials to bulk bags or drums for industrial lines. These specifications appear certified by Certificate of Analysis from each batch, providing a clear audit trail of compliance and purity every time urea pharmaceutical grade moves through supply chains. Its role as both a finished ingredient and a chemical intermediary places it at the intersection of science and commerce, with reliability depending on strong traceability.
Incidents involving accidental overexposure to concentrated urea remain rare when protocols follow globally recognized chemical safety standards. Proper ventilation in workspaces, coupled with routine training, helps prevent inhalation of dust or accidental ingestion, both far more likely during transfer or packaging than direct product use. Packing options need to keep moisture away and prevent accidental mixing with incompatible chemicals, since moisture can degrade product purity and damage packaging over time. In liquid or solution form, urea requires sealed, often plastic-lined containers to block leaching or reactivity with transport vessels. Regulatory oversight from shipping authorities means manifests include HS codes, hazard statements, and emergency data to help prevent and respond to spills or mishandling.
Feedstock selection and raw material quality checks set the stage for high-grade pharmaceutical urea production. Synthetic ammonia and carbon dioxide react under controlled conditions to yield this material, a process that benefits from energy efficiency improvements in modern facilities. Waste management of byproducts, responsible water use, and reductions in emissions from production cycle contribute to a lighter environmental footprint. While urea itself does not bioaccumulate or persist in the environment, manufacturing choices and off-site waste disposal practices deserve regular review, pushing producers to adopt cleaner, more sustainable methods without sacrificing purity or specification compliance. Proactive investments in pollution control and recycling technologies may ease concerns around chemical manufacture’s environmental legacy, all while maintaining accessible, affordable supply for medical users.
